MAGNESIUM SULPHATE 25 % SOLUTION FOR INJECTION
देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
उत्पाद विशेषताएं
(SPC)
11-06-2024
इस उत्पाद के लिए कुछ दस्तावेज़ वर्तमान में उपलब्ध नहीं हैं, आप हमारी ग्राहक सेवा को अनुरोध भेज सकते हैं और जैसे ही हम उन्हें प्राप्त करने में सक्षम होंगे, हम आपको सूचित करेंगे।
अनुरोध भेजा।
अनुरोध भेजा।
सक्रिय संघटक:
MAGNESIUM SULFATE HEPTAHYDRATE
थमां उपलब्ध:
Chanelle Pharmaceuticals Manufacturing Limited
ए.टी.सी कोड:
QA12CC02
INN (इंटरनेशनल नाम):
MAGNESIUM SULFATE HEPTAHYDRATE
डोज़:
25 %w/v
फार्मास्यूटिकल फॉर्म:
Solution for Injection
प्रिस्क्रिप्शन प्रकार:
LM-Licensed Merchant
चिकित्सीय समूह:
Bovine
चिकित्सीय क्षेत्र:
Magnesium sulfate
चिकित्सीय संकेत:
Vitamins & Minerals
प्राधिकरण का दर्जा:
Authorised
प्राधिकरण की तारीख:
1991-10-01
उत्पाद विशेषताएं
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Magnesium Sulphate 25% Solution for Injection.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Substance:
Magnesium Sulphate Heptahydrate 25.0 % w/v
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
A clear colourless sterile aqueous solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
It is indicated in the treatment of hypomagnesaemia and hypomagnesaemic tetany.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Administer with care particularly for very slow intravenous use. Intravenous injection should be given slowly and
stopped at once if untoward symptoms occur. As intravenous administration of this product could cause death, this
route should only be used by a veterinary surgeon. Use aseptic technique. Bring contents to body temperature in cold
weather prior to administration. Massage the subcutaneous site of injection during administration and for a short period
after.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
None.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 06/09/2011_
_CRN 7001284_
_page number: 1_
None known.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
This product may be used during pregnancy and lactation.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
None known.
4.9 AMOUNTS TO BE ADMINISTERED AND A
पूरा दस्तावेज़ पढ़ें
